
Capitol Health Limited
ASX:CAJ.AX
0.385 (AUD) • At close December 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 234.816 | 209.592 | 184.158 | 177.996 | 153.791 | 149.238 | 119.033 | 107.356 | 104.276 | 110.22 | 89.829 | 62.373 | 51.541 | 45.53 | 35.405 | 28.284 | 13.413 | 1.562 |
Cost of Revenue
| 190.072 | 172.352 | 145.854 | 133.441 | 126.655 | 115.476 | 89.102 | 78.599 | 73.487 | 72.278 | 61.25 | 44.483 | 2.385 | 1.789 | 2.741 | 1.712 | 0.688 | 0.287 |
Gross Profit
| 44.744 | 37.24 | 38.304 | 44.555 | 27.136 | 33.762 | 29.931 | 28.757 | 30.789 | 37.942 | 28.579 | 17.89 | 49.156 | 43.741 | 32.665 | 26.572 | 12.725 | 1.276 |
Gross Profit Ratio
| 0.191 | 0.178 | 0.208 | 0.25 | 0.176 | 0.226 | 0.251 | 0.268 | 0.295 | 0.344 | 0.318 | 0.287 | 0.954 | 0.961 | 0.923 | 0.939 | 0.949 | 0.817 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 155.344 | 141.111 | 119.352 | 106.997 | 96.047 | 101.986 | 78.445 | 4.395 | 3.345 | 4.483 | 3.914 | 2.769 | 36.042 | 29.76 | 26.318 | 22.471 | 10.293 | 0.967 |
Selling & Marketing Expenses
| 0 | -119.315 | -101.114 | -89.069 | -79.244 | -91.024 | -70.062 | 7.83 | 0.811 | 1.448 | 1.283 | 0.733 | 0.81 | 3.671 | 0.245 | 0.332 | 0.15 | 0.127 |
SG&A
| 155.344 | 21.796 | 18.238 | 17.928 | 16.803 | 10.962 | 8.383 | 12.225 | 11.357 | 12.97 | 10.818 | 7.368 | 36.042 | 29.76 | 26.563 | 22.803 | 10.443 | 1.095 |
Other Expenses
| 0 | -16.138 | 1.855 | -1.802 | 0.184 | -3.888 | -3.698 | 2.418 | -1.381 | -7.525 | 1.435 | 0.755 | 0.461 | 0.048 | -0.148 | 1.215 | -0.032 | 0.84 |
Operating Expenses
| 22.523 | 21.796 | 18.238 | 17.928 | 16.803 | 3.937 | 34.732 | 24.011 | 25.586 | 29.191 | 17.705 | 12.212 | 46.323 | 41.61 | 31.581 | 26.961 | 12.435 | 1.907 |
Operating Income
| 22.221 | 15.444 | 20.066 | 26.627 | 10.333 | 13.9 | 15.031 | 3.191 | 7.034 | 16.292 | 10.514 | 5.865 | 2.832 | 2.131 | 1.084 | -0.491 | 0.29 | -0.681 |
Operating Income Ratio
| 0.095 | 0.074 | 0.109 | 0.15 | 0.067 | 0.093 | 0.126 | 0.03 | 0.067 | 0.148 | 0.117 | 0.094 | 0.055 | 0.047 | 0.031 | -0.017 | 0.022 | -0.436 |
Total Other Income Expenses Net
| -33.724 | 21.679 | -25.177 | -7.186 | -8.17 | 11.145 | -23.397 | -0.736 | -18.939 | -8.504 | -7.57 | -0.552 | 0.121 | -0.803 | -0.456 | -1.099 | -0.003 | -0.285 |
Income Before Tax
| -11.503 | -10.074 | 15.949 | 19.441 | 2.163 | 28.17 | -9.12 | 2.454 | 2.96 | 7.787 | 10.191 | 5.313 | 2.953 | 1.328 | 0.628 | -1.59 | 0.287 | -0.966 |
Income Before Tax Ratio
| -0.049 | -0.048 | 0.087 | 0.109 | 0.014 | 0.189 | -0.077 | 0.023 | 0.028 | 0.071 | 0.113 | 0.085 | 0.057 | 0.029 | 0.018 | -0.056 | 0.021 | -0.618 |
Income Tax Expense
| 3.258 | 1.199 | 4.981 | 7.413 | 1.075 | 3.863 | 1.936 | 0.71 | 1.276 | 3.923 | 2.958 | 1.686 | 0.819 | 0.366 | -0.077 | -0.269 | 0.14 | 0.035 |
Net Income
| -14.853 | -11.393 | 10.732 | 11.919 | 0.865 | 27.534 | -11.056 | 1.744 | 1.684 | 3.864 | 7.233 | 3.627 | 2.134 | 0.962 | 0.705 | -1.018 | 0.215 | -0.966 |
Net Income Ratio
| -0.063 | -0.054 | 0.058 | 0.067 | 0.006 | 0.184 | -0.093 | 0.016 | 0.016 | 0.035 | 0.081 | 0.058 | 0.041 | 0.021 | 0.02 | -0.036 | 0.016 | -0.618 |
EPS
| -0.014 | -0.011 | 0.01 | 0.012 | 0.001 | 0.035 | -0.014 | 0.003 | 0.003 | 0.008 | 0.017 | 0.009 | 0.007 | 0.003 | 0.002 | -0.004 | 0.001 | -0.017 |
EPS Diluted
| -0.014 | -0.011 | 0.01 | 0.011 | 0.001 | 0.034 | -0.014 | 0.003 | 0.003 | 0.008 | 0.017 | 0.009 | 0.006 | 0.003 | 0.002 | -0.004 | 0.001 | -0.017 |
EBITDA
| 23.408 | 19.84 | 41.126 | 44.228 | 31.9 | 22.8 | 3.101 | 8.815 | 11.661 | 21.221 | 14.049 | 7.952 | 5.647 | 3.9 | 2.601 | 0.183 | 0.992 | -0.881 |
EBITDA Ratio
| 0.1 | 0.09 | 0.223 | 0.27 | 0.236 | 0.153 | 0.181 | 0.082 | 0.112 | 0.193 | 0.156 | 0.129 | 0.106 | 0.089 | 0.073 | 0.077 | 0.074 | -0.404 |